Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT00720304 · COMPLETED
Trial details
- NCT number
- NCT00720304
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-19
- Primary completion
- 2015-11-13
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.